Overview


According to FutureWise analysis the market for animal vaccines in 2023 is US$ 14.03 billion, and is expected to reach US$ 29.26 billion by 2031 at a CAGR of 9.60%.

Animal vaccines are specialized substances created to trigger an immune response in animals, protecting them from specific contagious ailments. These vaccines play a vital role in curbing the spread and occurrence of diseases across a wide range of animal types, encompassing livestock, pets, poultry, and aquatic creatures. To develop these vaccines, weakened or inactivated pathogens, their constituents, or engineered proteins are employed to mimic the disease-causing agent's presence without inducing illness. When animals are vaccinated, their immune systems produce antibodies and immune cells that confer resistance to the targeted ailment, lowering the risk of infection and its associated health and economic consequences. The significance of animal vaccines lies in their contribution to animal well-being, sustaining food production, and averting potential transmission of diseases to humans.

Animal vaccines not only prevent diseases among animals but also contribute to human health by reducing the potential for zoonotic disease transmission. They are integral to sustaining food production, supporting livelihoods, and ensuring the overall well-being of animals and humans alike. Ongoing research and innovation in vaccine development continue to expand animal vaccines' capabilities and potential applications, making them indispensable tools in modern agriculture and animal care.

FutureWise Market Research has published a report that provides an insightful analysis of Animal Vaccines Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Animal Vaccines Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Merck & Co. Inc.
  • Zoetis, Inc.
  • Elanco (Bayer Animal Health)
  • Boehringer Ingelheim
  • Indian Immunologicals Ltd.
  • Phibro Animal Health Corporation
  • Neogen corporation
  • Intas Pharmaceuticals Ltd.
  • Ceva 
  • Virbac

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Animal Vaccines Market:

  • In September 2022, Merck Animal Health made a significant contribution by donating over five million doses of its NOBIVAC rabies vaccine. The donation was directed towards supporting the eradication of canine-mediated rabies, and the recipients of this donation included their strategic collaborators Mission Rabies and Rabies Free Africa, facilitated through the Afya Program.
  • In May 2022, Ceva Santé Animale (Ceva) took a strategic step by acquiring Artemis Technologies Inc., a notable manufacturer of oral rabies vaccines based in Canada. Through this acquisition, Ceva successfully extended its footprint into the North American market, enhancing its presence within this crucial segment.

Several vital factors drive the animal vaccine market. One significant driver is the rising global population and increased demand for animal-derived sources of protein, including milk, meat, and eggs. This surge in demand underscores the importance of maintaining healthy and disease-resistant livestock, driving the adoption of animal vaccines as a preventive measure. Moreover, a growing focus on animal health and welfare, driven by heightened awareness of ethical treatment and overall well-being, is propelling the demand for vaccines that ensure the optimal health of animals. The emergence of new diseases and the re-emergence of previously controlled ailments underscore the necessity for continuous vaccine development to combat evolving pathogens effectively. Additionally, concerns about zoonotic diseases and their potential transmission from animals to humans, as evident from recent outbreaks like COVID-19, highlight the crucial role of animal vaccination in preventing such cross-species transmissions.

Despite these promising drivers and opportunities, the animal vaccine market faces challenges and restraints. High research and development costs associated with creating, testing, and gaining regulatory approval for new vaccines can be a barrier, potentially limiting the entry of smaller companies or hindering innovation. Navigating the complex and varied regulatory landscapes across different regions and countries can pose challenges, causing delays in introducing new vaccines to the market. Vaccine hesitancy and limited awareness among animal owners or producers about the benefits of vaccination may impact the uptake of vaccines, hindering disease prevention efforts. Moreover, disruptions in the supply chain, as exemplified by the COVID-19 pandemic, can impact the availability and distribution of vaccines, affecting disease control initiatives. As the drive to reduce antibiotic use in animal’s gains momentum, the market may witness increased demand for alternative disease prevention methods, potentially influencing the growth of the animal vaccine sector. Additionally, economic challenges faced by small-scale farmers, especially in low-income regions, may hinder their ability to afford and invest in disease prevention measures, affecting overall market dynamics.

By Product

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Animal Type

  • Livestock
    • Poultry
    • Aqua
    • Ruminants
    • Swine
  • Companion
    • Canine
    • Feline
    • Others

By Route of Administration

  • Subcutaneous
  • Intramuscular
  • Intranasal

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America maintained its market dominance in 2022, a trend projected to persist throughout the forecast period. This notable presence is underpinned by the region's high prevalence of livestock and zoonotic diseases, often resulting in substantial animal fatalities. Additionally, the formidable presence of established pharmaceutical companies, committed to robust vaccine commercialization and expanding market reach, is anticipated to propel growth. The increasing prevalence of canine ailments, driving higher vaccination adoption rates, and the burgeoning pet population in the U.S., further contribute to the region's market expansion.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the of Animal Vaccines Market by product, by animal type, by route of administration, by region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Vaccines Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Vaccines Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Vaccines Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Vaccines Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Attenuated Live Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. DNA Vaccines
        5. Recombinant Vaccines

  • 8.   Animal Vaccines Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Livestock
         1.1. Poultry
         1.2. Aqua
         1.3. Ruminants
         1.4. Swine
        2. Companion
         2.1. Canine
         2.2. Feline
         2.3. Others

  • 9.   Animal Vaccines Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Subcutaneous
        2. Intramuscular
        3. Intranasal

  • 10.   North America Animal Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Animal Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Animal Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Animal Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Animal Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Merck & Co., Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Zoetis
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Elanco (Bayer Animal Health)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boehringer Ingelheim
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Indian Immunologicals Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Phibro Animal Health Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Neogen Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Intas Pharmaceuticals Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ceva
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Virbac
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11